drug delivery His ground-breaking method was initially scoffed at by the scientific community, but his relentless experimentation eventually laid the bedrock for cancer treatment and led to the founding of Covid-19 vaccine giant Moderna.
Professor Robert Langer recounted his journey in the drug development industry at the 11th Global Young Scientist Summit, held at the Singapore University of Design and Technology on Jan 18.
Prof Langer, 74, graduated with a doctorate in chemical engineering from the Massachusetts Institute of Technology (MIT). However, he applied for post-doctorate jobs in the medical industry because of his passion to help people. Unsurprisingly, no one would hire him because his field was unrelated to medicine.
But he remained committed to his calling, and was advised by an older scientist to try Dr Judah Folkman, a Harvard University professor and surgeon-in-chief at Boston Children's Hospital who who was known for hiring people with unusual backgrounds.
Prof Langer landed a job as Dr Folkman's assistant and began working at the hospital in 1974.
Dr Folkman was studying metastasis, the process of how cancerous tumours grow and spread throughout the body. He theorised that tumours stimulated angiogenesis, or the growth of blood vessels, to provide them with nutrients and allow them to spread.
He tasked Prof Langer to find a method to deliver angiogenesis-inhibiting drugs to the tumour.
"I spent years in the laboratory experimenting with different materials and different designs to deliver the drugs. I found 200 different ways not to get this done." said Prof Langer at the summit.
"But eventually, I was able to make tiny little nanoparticles which could deliver molecules of any size, including nucleic acids and mRNA."
Bu hikaye The Straits Times dergisinin January 30, 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye The Straits Times dergisinin January 30, 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
GAWILAN EYES PARIS PEAK
But before that, the Filipino is set to duel with Toh at OCBC Aquatic Centre
DOI WANTS TO BE SPL LEGEND ON RETURN
After tough’ stints, 2021 Player of the Year looks to make a bigger impact with Geylang
Intensity helps Paul to unlock Hurkacz
When things got a little topsy-turvy at the Italian Open quarter-finals on May 16, Tommy Paul told himself that he had to up the \"intensity\" to win.
DONCIC PLAYS SMILING ASSASSIN
Slovenian star finds his focus as Mavericks silence Thunder; Celtics see off Cavaliers
VJC TEAMS FLOOR RIVALS IN A DIVISION
Boys survive tense test in shoot-out win over RI as girls avenge loss to River Valley
SIA shares slip amid Investor concerns over rise In costs
Carrier says it is well-positioned despite headwinds as competition intensifies
Red Sea disruptions fragmenting global LNG trade into regions
LONDON It has been four months since a liquefied natural gas (LNG) tanker has passed through the narrow strait separating the Arabian Peninsula and Africa, testament to how violent attacks there have upended global energy trade.
Charles Keith’s co-founder named Businessman of the Year
Charles Wong lauded for role in turning shoe retailer into global fashion brand
Amazon workers say they struggle to afford food, rent
But firm describes study on US employees’ economic well-being as deeply flawed’
SUTD partners 12 institutions to enhance design education
Global alliance to explore student and faculty exchanges; it includes schools in Beijing, NY